| Data set | Procedure | What's in this data set | Panel | Sex | Age (weeks) | Year |
|---|---|---|---|---|---|---|
|
|
body weight
with Theiler's murine encephalomyelitis virus |
Body weight | CC (5) | both | 4wks | 2017 |
|
|
gait analysis
with Theiler's murine encephalomyelitis virus |
DigiGait analysis and footprint analysis, TMEV infection. | CC (5) | both | 4wks | 2017 |
|
|
health assessment
with Theiler's murine encephalomyelitis virus |
Clinical health assessment scores, TMEV infection. | CC (5) | both | 4wks | 2017 |
|
|
open field test
with Theiler's murine encephalomyelitis virus |
Locomotor activity, TMEV infection. | CC (5) | both | 4wks | 2017 |
|
|
RNA expression profiling
with Theiler's murine encephalomyelitis virus |
TMEV transcript abundance. | CC (5) | both | 4wks | 2017 |
|
|
rotarod
with Theiler's murine encephalomyelitis virus |
Latency to fall from accelerating rotarod, TMEV infection. | CC (5) | both | 4wks | 2017 |
|
|
bottle choice test | Palatable food consumption, preference for Boost solution. | CC w/par (18) | both | 10-39wks | 2023 |
|
|
open field test | Locomotor response to novelty, habituation. | CC w/par (18) | both | 10-39wks | 2023 |
|
|
operant conditioning chamber | Reversal learning (impulsive action) and delay discounting (impulsive choice). | CC w/par (18) | both | 10-39wks | 2023 |
|
|
conditioned place preference test | In novel zone: exploration counts, entrance counts, time spent, activity counts, movement counts. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
hole board test | Number of entries, novel entries, and repeat entries. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
in vitro assay | Circadian parameters in fibroblast cultures: period, amplitude, phase, damping rate, goodness of fit. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
light-dark box | Distance traveled, ambulatory time and counts, resting time, stereotypic time and counts, jumping time and counts, vertical time and counts, time in light/dark. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
open field test
with cocaine |
Distance traveled, habituation ratio, number of rears, ambulatory time, time in perimeter, corners, and center; cocaine sensitization. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
operant conditioning chamber
with cocaine |
Number of infusions, active lever presses, inactive lever presses, intravenous self administration, reversal learning. | CC w/CC8 (61) | both | 4-25wks | 2021 |
|
|
ABR test | Auditory brainstem response. | CC (18) | both | various | 2018 |
|
|
acoustic startle test | Acoustic startle response, prepulse inhibition. | CC (18) | both | various | 2018 |
|
|
complete blood count | Hematology. | CC (18) | both | various | 2018 |
|
|
DXA | Body mass, fat mass, lean mass, bone mineral density and content, bone area. | CC (18) | both | various | 2018 |
|
|
ECG | Heart rate and wave intervals. Conscious. | CC (18) | both | various | 2018 |
|
|
grip strength | 3 trials. | CC (18) | both | various | 2018 |
|
|
hole board test | Exploratory behavior. | CC (18) | both | various | 2018 |
|
|
hormone quantification | Insulin (plasma). | CC (18) | both | various | 2018 |
|
|
light-dark box | Anxiety, avoidance behavior. 20 min test. | CC (18) | both | various | 2018 |
|
|
lipid profile | Cholesterol, HDL, triglycerides, fatty acids. No fast, plasma. | CC (18) | both | various | 2018 |
|
|
metabolic panel | Clinical blood chemistry (plasma). No fast. | CC (18) | both | various | 2018 |
|
|
open field test | Locomotor, exploratory, and anxiety-related behavior. 20 min test, some at 5 min intervals. | CC (18) | both | various | 2018 |
|
|
organ weights | Heart weight. Raw and normalized to body weight. | CC (18) | both | various | 2018 |
|
|
rotarod | Latency to fall from accelerating rotarod. 5 trials. | CC (18) | both | various | 2018 |
|
|
tail suspension test | Latency to immobility, duration of immobility. | CC (18) | both | various | 2018 |
|
|
urinalysis | Microalbumin, creatinine, ratio. | CC (18) | both | various | 2018 |
|
|
colony observation | Litter size assessment. | CC (12) | m | 13-21wks | 2018 |
|
|
microscopy | Male reproductive sperm motility. Computer assisted sperm analysis. | CC (12) | m | 13-21wks | 2018 |
|
|
organ weights | Testis weight. | CC (12) | m | 13-21wks | 2018 |
|
|
sperm count | Sperm count. Computer assisted sperm analysis. | CC (12) | m | 13-21wks | 2018 |
|
|
immune cell quantification | Immunological cell variation. | CC w/par (76) | both | 5-8wks | 2018 |
|
|
immune cell quantification | total number of splenocytes, number of B cells in spleen, and percentage of splenocytes that are B cells | CC w/par (76) | both | 5-8wks | 2024 |
|
|
body weight | Body weight | CC (16) | both | 10wks | 2015 |
|
|
rotarod | Speed where mouse falls off accelerating rotarod, 45 degree angle, 3-5 trials. | CC (16) | both | 10wks | 2015 |
|
|
body weight | Body weight | CC (50) | f | 17-72wks | 2017 |
|
|
MRI | Body composition (fat and lean mass and percent). | CC (50) | f | 17-72wks | 2017 |
|
|
treadmill endurance test | Maximal distance is recorded when mouse fails to run. | CC (50) | f | 17-72wks | 2017 |
|
|
running wheel monitoring | Running wheel activity each day for 28 days. | CC (43) | f | 5-22wks | 2017 |
|
|
body weight | Body weight before, during, and after several weeks of exercise. | CC (43) | f | 20-88wks | 2017 |
|
|
intake monitoring | Food intake, before, during, and after several weeks of exercise. | CC (43) | f | 20-88wks | 2017 |
|
|
MRI | Body composition (fat and lean mass) before, during, and after several weeks of exercise. | CC (43) | f | 20-88wks | 2017 |
|
|
body weight
with exercise |
Body weight before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
intake monitoring
with exercise |
Food intake during 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
MRI
with exercise |
Body composition (fat and lean mass) before and after 2 weeks of exercise wheel availability. | CC (13) | f | 32-40wks | 2018 |
|
|
running wheel monitoring
with exercise |
Running wheel activity on days 11 and 12. | CC (13) | f | 32-40wks | 2018 |
|
|
study archive
with exercise |
Activity levels, body weight and composition after voluntary exercise. | CC (2) | f | 14-18wks | 2018 |
|
|
body weight
with exercise |
Body weight before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
MRI
with exercise |
Body composition (fat and lean mass) before and after 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
intake monitoring
with exercise |
Food and water intake, during 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
monitoring system
with exercise |
Locomotor activity, respiratory activity, body heat production, during 4 weeks of treadmill-based exercise training. 3 intensity cohorts. | CC (4) | both | 8-10wks | 2018 |
|
|
body weight | Body weight | CC (52) | m | 7-20wks | 2018 |
|
|
monitoring system | Social interaction and discrimination; activity, digging, grooming. | CC (52) | m | 7-20wks | 2018 |
|
|
organ weights | Brain weight. | CC (52) | m | 7-20wks | 2018 |
|
|
study archive
with tetrachloroethylene |
Toxicokinetics and toxicodynamics of tetrachloroethylene exposure. | CC (45) | both | 2016 | |
|
|
study archive
with trichloroethylene |
Trichloroethylene exposure. | CC (45) | m | 2017 | |
|
|
body weight | Body weight | CC (12) | m | 15-33wks | 2020 |
|
|
histopathology | Male reproductive histopathology. Percent normal, abnormal sperm. | CC (12) | m | 15-33wks | 2020 |
|
|
microscopy | Sperm motility | CC (12) | m | 15-33wks | 2020 |
|
|
organ weights | Male reproductive organ weights. Testes, seminal vesicles, epididymis + vas deferens. | CC (12) | m | 15-33wks | 2020 |
|
|
sperm count | Sperm count. Hemocytometer. | CC (12) | m | 15-33wks | 2020 |
|
|
microscopy | Sperm motility. | CC (12) | m | 15-33wks | 2020 |
|
|
genotyping | SNP profiling, 130,000+ genomic locations, 1-19,X,Y,MT. | CC w/par (77) | m | 2020 | |
|
|
genotyping | SNP profiling, 76,000+ genomic locations, 1-19,X,MT | CC w/par (77) | both | 2017 | |
|
|
glycosylation profile | IgG glycan peaks, relative abundance | CC (111) | both | 4-140wks | 2018 |
|
|
glycosylation profile | IgG subclasses, relative abundance | CC (95) | both | 20-117wks | 2018 |